- Mabtech and Sai Life Sciences have entered a strategic collaboration to establish Sai’s Boston laboratory as a co-marketed US execution and demonstration hub for the EYRA™ immunoassay platform.
- The partnership will support the delivery of advanced immunology assay services for biopharma and biotech companies across immuno-oncology, vaccines, inflammation, and cellular therapy.
Mabtech and Sai Life Sciences have announced a strategic collaboration that designates Sai’s Boston discovery laboratory as a co-marketed US execution and demonstration hub for the Mabtech EYRA™ platform. The collaboration is focused on expanding access to advanced immunology assay capabilities for biopharma and biotech customers.
Under the agreement, the companies will jointly deliver immunology assay services powered by the EYRA platform installed at Sai’s Boston site. Services will include high-sensitivity multiplex cytokine and phenotyping workflows, supporting research programs in immuno-oncology, vaccines, inflammation, and cellular therapy.
“We’re excited to see EYRA placed at Sai Life Sciences and integrated into their US discovery operations. The installation enables broader access to multiplex immunology readouts for Sai’s customer base.”
Kimberlee Parent, Head of US Operations at Mabtech
EYRA is designed to support simultaneous detection of dozens of analytes in a single run, with automation-ready workflows and reduced hands-on time. According to the companies, the platform addresses limitations associated with traditional flow-based and plate-based immunoassay systems, enabling more streamlined immune profiling.
“For our discovery clients, the ability to generate reliable, decision-enabling data early is critical.”
Maneesh Pingle, Head of Discovery Services at Sai Life Sciences.
He added that positioning the Boston site as a US execution hub strengthens Sai’s discovery and translational service offering. The collaboration includes joint service delivery, co-branded demonstrations, shared thought leadership, and integrated business development engagement supporting discovery through translational research.
